Clozapine: dangerous orphan or neglected friend?
نویسندگان
چکیده
Evidence concerning the superior efficacy and effectiveness of clozapine has not fully informed routine clinical practice. This is possibly because of the perception that clozapine is a dangerous therapeutic agent. Clozapine use may actually promote longevity, and earlier use of clozapine in adequate dosages represents a neglected therapeutic opportunity in this age of stagnated antipsychotic innovation.
منابع مشابه
Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
Clozapine is a highly effective antipsychotic medication, which provides a range of significant benefits for patients with schizophrenia, and is the standard of care for treatment-resistant schizophrenia as well as for reducing the risk of suicidal behaviors in schizophrenia and schizoaffective disorder. However, clozapine is widely underutilized, largely because prescribing clinicians lack exp...
متن کاملClozapine: is now the time for more clinicians to adopt this orphan?
Although many patients with schizophrenia fail to respond adequately to trials of 2 or more antipsychotics, utilization of clozapine for these patients remains low, despite recommendations for its use by accepted treatment guidelines. Some experts estimate that 5-10 times more patients could benefit from clozapine than who are now receiving it. Learning how to manage the unique side effect prof...
متن کاملIncreasing R&D incentives for neglected diseases: Lessons from the Orphan Drug Act
1. Introduction 2. Economics of the pharmaceutical R&D process 2a. Costs and risks 2b. R&D returns 2c. The critical significance of patents in pharmaceuticals 3. The Orphan Drug Act of 1983 3a. Push and pull incentive programs 3b. Characteristics of the Orphan Drug Act 3c. Orphan drug designation and approvals 3d. Costs of orphan drugs 3e. Revenues from marketed orphan drugs 3f. Health benefits...
متن کاملکلوزاپین: انقلابی جدید در درمان شیزوفرنی
Clozapine is the first antipsycotic drug with a great efficacy. Thirty to fifty percent of treatment-resistant schizophrenics markedly improved with clozapine. Approximately, 25% of long-term patients, treated with clozapine, could be discharged. This improvement included negative as well as positive symptom areas. Clozapine produced no extrapyramidal side effects. Tardive dyskinesia, a major s...
متن کاملExpert Delphi survey on research and development into drugs for neglected diseases
BACKGROUND Tropical infectious diseases are called neglected, because they are, inter alia, characterized by an R&D deficit. A similar deficit exists for rare (orphan) diseases which neither promise a sufficient return on R&D investment. To encourage the development of treatments for rare diseases, orphan drug acts were created which contain financial and non-financial incentives for the pharma...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The British journal of psychiatry : the journal of mental science
دوره 198 4 شماره
صفحات -
تاریخ انتشار 2011